Harrison, S. A., Abdelmalek, M. F., Diehl, A. M., Caldwell, S., Shiffman, M. L., Ghalib, R., … Sanyal, A. J. (2017). Prospective validation of the Enhanced Liver Fibrosis (ELF) test for the prediction of disease progression in patients with nonalcoholic steatohepatitis (NASH) and advanced fibrosis. In HEPATOLOGY (Vol. 66, pp. 1120A-1121A). Washington, DC: WILEY.

Harrison, Stephen A., Manal F. Abdelmalek, Anna Mae Diehl, Stephen Caldwell, Mitchell L. Shiffman, Reem Ghalib, Eric Lawitz, et al. “Prospective validation of the Enhanced Liver Fibrosis (ELF) test for the prediction of disease progression in patients with nonalcoholic steatohepatitis (NASH) and advanced fibrosis.” In HEPATOLOGY, 66:1120A-1121A. WILEY, 2017.

Harrison SA, Abdelmalek MF, Diehl AM, Caldwell S, Shiffman ML, Ghalib R, et al. Prospective validation of the Enhanced Liver Fibrosis (ELF) test for the prediction of disease progression in patients with nonalcoholic steatohepatitis (NASH) and advanced fibrosis. In: HEPATOLOGY. WILEY; 2017. p. 1120A-1121A.

Harrison, Stephen A., et al. “Prospective validation of the Enhanced Liver Fibrosis (ELF) test for the prediction of disease progression in patients with nonalcoholic steatohepatitis (NASH) and advanced fibrosis.” HEPATOLOGY, vol. 66, WILEY, 2017, pp. 1120A-1121A.

Harrison SA, Abdelmalek MF, Diehl AM, Caldwell S, Shiffman ML, Ghalib R, Lawitz E, Rockey DC, Schall REA, Jia C, McColgan BJ, Myers RP, Subramanian M, McHutchison JG, Muir AJ, Ratziu V, Afdhal NH, Goodman ZD, Bosch J, Sanyal AJ. Prospective validation of the Enhanced Liver Fibrosis (ELF) test for the prediction of disease progression in patients with nonalcoholic steatohepatitis (NASH) and advanced fibrosis. HEPATOLOGY. WILEY; 2017. p. 1120A-1121A.